Committee recommends narrowing glucose‑monitoring coverage bill rather than advancing current draft

The Commerce and Consumer Affairs Committee debated House Bill 1571 — a proposal to require health carriers to cover continuous glucose‑monitoring devices — and recorded a committee blurb describing the bill as "too broad in scope." A committee member read the blurb into the record and the panel voted to mark the bill not recommended in its current form while recommending that sponsors reintroduce a narrowed bill.

The blurb read by the committee summarized the bill as a requirement for carriers to cover continuous glucose monitoring for anyone with diabetes or hypoglycemia, described existing coverage for people on insulin in the New Hampshire market, and concluded that the current draft could not bound cost. It recommended rewriting the bill to limit eligibility (the blurb suggested persons diagnosed with type 2 diabetes on therapies other than insulin) and to handle Medicaid coverage in a separate bill.

Members spent significant time clarifying that the committee's vote on the draft did not mean they oppose the underlying policy goal. Several members said they support additional legislation that addresses affordability and access but that this draft required narrowing before the committee could recommend it in writing. The committee recorded its vote and asked volunteers to prepare the committee blurb and supporting numbers for the record.